Novel insights into conjugation of antitumor-active unsymmetrical bisacridine C-2028 with glutathione: Characteristics of non-enzymatic and glutathione S-transferase-mediated reactions
Unsymmetrical bisacridines (UAs) are a novel potent class of antitumor-active therapeutics. A significant route of phase II drug metabolism is conjugation with glutathione (GSH), which can be non-enzymatic and/or catalyzed by GSH-dependent enzymes. The aim of this work was to investigate the GSH-med...
Saved in:
Main Authors: | Agnieszka Potęga (Author), Michał Kosno (Author), Zofia Mazerska (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells
by: Anna Mieszkowska, et al.
Published: (2021) -
pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy
by: Joanna Pilch, et al.
Published: (2023) -
Glutathione S-transferase π: a potential role in antitumor therapy
by: Dong S, et al.
Published: (2018) -
Glutathione S-Transferases in Cancer
by: Rahul Raj Singh, et al.
Published: (2021) -
Electrochemical and in silico approaches for liver metabolic oxidation of antitumor-active triazoloacridinone C-1305
by: Agnieszka Potęga, et al.
Published: (2020)